
Nicholas J. Weiss
Examiner (ID: 18899, Phone: (571)270-1775 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3754, 3711, 3781 |
| Total Applications | 524 |
| Issued Applications | 306 |
| Pending Applications | 35 |
| Abandoned Applications | 187 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19343636
[patent_doc_number] => 20240252599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => ALKALINE PHOSPHATASE-BASED TREATMENTS OF CELIAC DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/563277
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563277
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563277 | ALKALINE PHOSPHATASE-BASED TREATMENTS OF CELIAC DISEASE | May 23, 2022 | Pending |
Array
(
[id] => 18347324
[patent_doc_number] => 20230135434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/748096
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748096 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | May 18, 2022 | Abandoned |
Array
(
[id] => 17867343
[patent_doc_number] => 20220290079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => Pichia kudriavzevii and multifunctional complex microbial inoculant and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/748304
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748304 | None | May 18, 2022 | Issued |
Array
(
[id] => 19281909
[patent_doc_number] => 20240218383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => RECOMBINANT YEASTS FOR PRODUCING ACETONE AND/OR ISOPROPANOL FROM FATTY ACID FEEDSTOCKS
[patent_app_type] => utility
[patent_app_number] => 18/557456
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557456 | RECOMBINANT YEASTS FOR PRODUCING ACETONE AND/OR ISOPROPANOL FROM FATTY ACID FEEDSTOCKS | May 10, 2022 | Pending |
Array
(
[id] => 19609600
[patent_doc_number] => 12158472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
[patent_app_type] => utility
[patent_app_number] => 17/741865
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 37
[patent_no_of_words] => 10137
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741865 | Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same | May 10, 2022 | Issued |
Array
(
[id] => 19296448
[patent_doc_number] => 20240225011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => MICROBIAL INOCULANTS FOR PLANT ROOTING CAPACITY AND GERMINATION RATE
[patent_app_type] => utility
[patent_app_number] => 18/559249
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559249
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559249 | MICROBIAL INOCULANTS FOR PLANT ROOTING CAPACITY AND GERMINATION RATE | May 8, 2022 | Pending |
Array
(
[id] => 19120043
[patent_doc_number] => 11964004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Short in vivo half-life and in vivo unstable recombinant microplasmin, pharmaceutical composition comprising thereof and method of treating thromboembolism related diseases including administration thereof
[patent_app_type] => utility
[patent_app_number] => 17/709403
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 13178
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17709403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/709403 | Short in vivo half-life and in vivo unstable recombinant microplasmin, pharmaceutical composition comprising thereof and method of treating thromboembolism related diseases including administration thereof | Mar 29, 2022 | Issued |
Array
(
[id] => 19297634
[patent_doc_number] => 20240226200
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/279040
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279040
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279040 | PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS | Mar 28, 2022 | Pending |
Array
(
[id] => 19297634
[patent_doc_number] => 20240226200
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/279040
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279040
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279040 | PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS | Mar 27, 2022 | Pending |
Array
(
[id] => 19170948
[patent_doc_number] => 20240156922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => FUNGAL PROTEASE MIXTURES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/552254
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552254
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552254 | FUNGAL PROTEASE MIXTURES AND USES THEREOF | Mar 24, 2022 | Pending |
Array
(
[id] => 19462450
[patent_doc_number] => 20240316119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/277572
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277572
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277572 | COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS | Feb 17, 2022 | Pending |
Array
(
[id] => 19249065
[patent_doc_number] => 20240200052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => METHOD FOR PRODUCING TAGATOSE FROM BIOMIMETIC SILICON MINERALIZED MICROCAPSULE IMMOBILIZED MULTI-ENZYME
[patent_app_type] => utility
[patent_app_number] => 18/554464
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554464
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554464 | METHOD FOR PRODUCING TAGATOSE FROM BIOMIMETIC SILICON MINERALIZED MICROCAPSULE IMMOBILIZED MULTI-ENZYME | Feb 10, 2022 | Pending |
Array
(
[id] => 19114039
[patent_doc_number] => 20240125789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => HYBRID AMEBOCYTE LYSATE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/275777
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275777 | HYBRID AMEBOCYTE LYSATE AND USES THEREOF | Feb 10, 2022 | Abandoned |
Array
(
[id] => 17928320
[patent_doc_number] => 20220323445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => REDUCING IMMUNOGENICITY TO PEGLOTICASE
[patent_app_type] => utility
[patent_app_number] => 17/668015
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668015 | REDUCING IMMUNOGENICITY TO PEGLOTICASE | Feb 8, 2022 | Abandoned |
Array
(
[id] => 17733335
[patent_doc_number] => 20220218794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITIONS AND METHODS FOR DETOXIFYING BACTERIAL ENDOTOXINS
[patent_app_type] => utility
[patent_app_number] => 17/592623
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592623 | COMPOSITIONS AND METHODS FOR DETOXIFYING BACTERIAL ENDOTOXINS | Feb 3, 2022 | Abandoned |
Array
(
[id] => 19947074
[patent_doc_number] => 12318412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/577208
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 6663
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577208 | None | Jan 16, 2022 | Issued |
Array
(
[id] => 18988128
[patent_doc_number] => 20240060097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => BIOCONVERSION OF FERULIC ACID TO VANILLIN
[patent_app_type] => utility
[patent_app_number] => 18/267478
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267478
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267478 | BIOCONVERSION OF FERULIC ACID TO VANILLIN | Dec 16, 2021 | Abandoned |
Array
(
[id] => 17519313
[patent_doc_number] => 20220105161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME
[patent_app_type] => utility
[patent_app_number] => 17/551942
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551942 | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME | Dec 14, 2021 | Abandoned |
Array
(
[id] => 18986459
[patent_doc_number] => 20240058428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => COMPOSITION FOR TREATING OR PREVENTING MYOPATHY, OBESITY OR DIABETES
[patent_app_type] => utility
[patent_app_number] => 18/267252
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267252
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267252 | Composition for treating or preventing myopathy, obesity or diabetes | Dec 13, 2021 | Issued |
Array
(
[id] => 18986786
[patent_doc_number] => 20240058755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => CONTINUOUS ENZYMATIC PERFUSION REACTOR SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/265838
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265838
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265838 | CONTINUOUS ENZYMATIC PERFUSION REACTOR SYSTEM | Dec 12, 2021 | Abandoned |